Cross-Presentation of Synthetic Long Peptides by Human Dendritic Cells: A Process Dependent on ERAD Component p97/VCP but Not sec61 and/or Derlin-1

Antitumor vaccination using synthetic long peptides (SLP) is an additional therapeutic strategy currently under development. It aims to activate tumor-specific CD8(+) CTL by professional APCs such as DCs. DCs can activate T lymphocytes by MHC class I presentation of exogenous antigens - a process re...

Descripción completa

Detalles Bibliográficos
Autores principales: Ménager, Jérémie, Ebstein, Frédéric, Oger, Romain, Hulin, Philippe, Nedellec, Steven, Duverger, Eric, Lehmann, Andrea, Kloetzel, Peter-Michael, Jotereau, Francine, Guilloux, Yannick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937416/
https://www.ncbi.nlm.nih.gov/pubmed/24587108
http://dx.doi.org/10.1371/journal.pone.0089897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937416/
https://www.ncbi.nlm.nih.gov/pubmed/24587108
http://dx.doi.org/10.1371/journal.pone.0089897

Ejemplares similares